Patient care in the allergy and respiratory fields is advancing rapidly, offering the possibility of the inclusion of a variety of digital tools that aim to improve outcomes of care. Impaired access to several health care facilities during the COVID-19 pandemic has considerably increased the appetite and need for the inclusion of e-health tools amongst end-users. Consequently, a multitude of different e-health tools have been launched worldwide with various registration and access options, and with a wide range of offered benefits. From the perspective of both patients and healthcare providers (HCPs), as well as from a legal and device-related perspective, several features are important for the acceptance, effectiveness,and long-term use of e-health tools. Patients and physicians have different needs and expectations of how digital tools might be of help in the care pathway. There is a need for standardization by defining quality assurance criteria. Therefore, the Upper Airway Diseases Committee of the World Allergy Organization (WAO) has taken the initiative to define and propose criteria for quality, appeal, and applicability of e-health tools in the allergy and respiratory care fields from a patient, clinician, and academic perspective with the ultimate aim to improve patient health and outcomes of care.

Allergy and Immunology Section Department of Medicine Hamad Medical Corporation Qatar

Center for Rhinology and Allergology Wiesbaden Germany

Clinical Associate American University of Beirut Medical Center Beirut Lebanon

Consultant Gastroenterologist Clemenceau Medical Center Beirut Lebanon

Department of Allergology and Immunology Universidad Autonoma de Nuevo Leon Monterrey Mexico

Department of Allergology Clinical Medicine Griffith University of Queensland Griffith Australia

Department of Allergy and Clinical Immunology School of Health Sciences Catholic University of Salta Argentina

Department of Allergy and Immunology Hospital Quironsalud Bizkaia Erandio Spain

Department of Allergy and Immunology Louisiana State University School of Medicine Shreveport USA

Department of Allergy and Otolaryngology Lebanese American University Medical Center Beirut Lebanon

Department of Allergy and Respiratory Medicine InAER Buenos Aires Argentina

Department of Allergy Asthma and Clinical Immunology Georgetown University School of Medicine Washington DC USA

Department of Allergy Immunology and Rheumatology American University of Beirut Lebanon

Department of Audiology and Neurotology Edouard Herriot Hospital Lyon France

Department of Clinical Immunology and Allergy Cleveland Clinic Ohio USA

Department of Clinical Pharmacy and Pharmacology UMCG Groningen the Netherlands

Department of Internal Medicine American Hospital Dubai United Arab Emirates

Department of Internal Medicine and Clinical Immunology Hotel Dieu de France St Joseph University Beirut Lebanon

Department of Microbiology and Immunology Laboratory of Clinical Immunology KU Leuven Leuven Belgium

Department of Microbiology Faculty of Medicine Kuwait University Kuwait

Department of Microbiology Immunology and Transplantation KU Leuven Leuven Belgium

Department of Otolaryngology and Head and Neck Surgery University of North Carolina at Chapel Hill Chapel Hill USA

Department of Otolaryngology Head and Neck Surgery Eye and Ear University Hospital Beirut Lebanon

Department of Otolaryngology Head and Neck Surgery Holy Spirit University of Kaslik Eye and Ear Hospital Beirut Lebanon

Department of Otorhinolaryngology Academic Medical Center Amsterdam the Netherlands

Department of Otorhinolaryngology RNENT Hospital London London UK

Department of Otorhinolaryngology University Hospitals Leuven KU Leuven Leuven Belgium

Department of Pneumology and Allergology University Hospital of Benimessous Algiers Algeria

Department of Respiratory Medicine 1st Faculty of Medicine Charles University and Thomayer Hospital Prague Czech Republic

Department of Respiratory Medicine and Allergology Institute for Clinical Science Skane University Hospital Lund Sweden

Department of Rheumatology Allergy and Clinical Immunology University of Florida Florida USA

Department of Rhinology Head and Neck Surgery Eastern Virginia Medical School Norfolk VA USA

Division of Immunity and Infection Medical Sciences UCL London UK

EUFOREA European Forum for Research and Education in Allergy and Airway Diseases Brussels Belgium

Zobrazit více v PubMed

Committee G.S. 2021. 2021 GINA Report.

Wise S.K., Lin S.Y., Toskala E., et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108–352. PubMed

Fokkens W.J., Lund V.J., Hopkins C., et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(suppl S29):1–464. PubMed

Gopal G., Suter-Crazzolara C., Toldo L., Eberhardt W. Digital transformation in healthcare - architectures of present and future information technologies. Clin Chem Lab Med. 2019;57(3):328–335. PubMed

De Groot J., Wu D., Flynn D., Robertson D., Grant G., Sun J. Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: a meta-analysis. World J Diabetes. 2021;12(2):170–197. PubMed PMC

Jeffrey B., Bagala M., Creighton A., et al. Mobile phone applications and their use in the self-management of Type 2 Diabetes Mellitus: a qualitative study among app users and non-app users. Diabetol Metab Syndrome. 2019;11:84. PubMed PMC

Lane D.A., McMahon N., Gibson J., et al. Mobile health applications for managing atrial fibrillation for healthcare professionals and patients: a systematic review. Europace. October 2020;22(10):1567–1578. PubMed

Buss V.H., Leesong S., Barr M., Varnfield M., Harris M. Primary prevention of cardiovascular disease and type 2 diabetes mellitus using mobile health technology: systematic review of the literature. J Med Internet Res. 2020;22(10):e21159. PubMed PMC

Franklin N.C., Lavie C.J., Arena R.A. Personal health technology: a new era in cardiovascular disease prevention. Postgrad Med. 2015;127(2):150–158. PubMed PMC

Matthews P.M., Block V.J., Leocani L. E-health and multiple sclerosis. Curr Opin Neurol. 2020;33(3):271–276. PubMed

Ginis P., Nieuwboer A., Dorfman M., et al. Feasibility and effects of home-based smartphone-delivered automated feedback training for gait in people with Parkinson's disease: a pilot randomized controlled trial. Park Relat Disord. 2016;22:28–34. PubMed

Whitehead L., Seaton P. The effectiveness of self-management mobile phone and tablet apps in long-term condition management: a systematic review. J Med Internet Res. 2016;18(5):e97. PubMed PMC

Finkelstein J., Knight A., Marinopoulos S., et al. Enabling patient-centered care through health information technology. Evid Rep Technol Assess. 2012;(206):1–1531. PubMed PMC

Hamine S., Gerth-Guyette E., Faulx D., Green B.B., Ginsburg A.S. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res. 2015;17(2):e52. PubMed PMC

de Jongh T., Gurol-Urganci I., Vodopivec-Jamsek V., Car J., Atun R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev. 2012;12(12):Cd007459. PubMed PMC

Slater H., Campbell J.M., Stinson J.N., Burley M.M., Briggs A.M. End user and implementer experiences of mHealth technologies for noncommunicable chronic disease management in young adults: systematic review. J Med Internet Res. 2017;19(12):e406. PubMed PMC

Dayer L., Heldenbrand S., Anderson P., Gubbins P.O., Martin B.C. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharmaceut Assoc. 2003;53(2):172–181. PubMed PMC

Lee J.A., Choi M., Lee S.A., Jiang N. Effective behavioral intervention strategies using mobile health applications for chronic disease management: a systematic review. BMC Med Inf Decis Making. 2018;18(1):12. PubMed PMC

Bashshur R.L., Shannon G.W., Smith B.R., et al. The empirical foundations of telemedicine interventions for chronic disease management. Telemed J e Health. 2014;20(9):769–800. PubMed PMC

Sleurs K., Seys S.F., Bousquet J., et al. Mobile health tools for the management of chronic respiratory diseases. Allergy. 2019;74(7):1292–1306. PubMed

Bédard A., Basagaña X., Anto J.M., et al. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: the MASK study. J Allergy Clin Immunol. 2019;144(1):135–143. e6. PubMed

Cingi C., Yorgancioglu A., Cingi C.C., et al. The "physician on call patient engagement trial" (POPET): measuring the impact of a mobile patient engagement application on health outcomes and quality of life in allergic rhinitis and asthma patients. Int Forum Allergy Rhinol. 2015;5(6):487–497. PubMed

Farzandipour M., Nabovati E., Sharif R., Arani M.H., Anvari S. Patient self-management of asthma using mobile health applications: a systematic review of the functionalities and effects. Appl Clin Inf. 2017;8(4):1068–1081. PubMed PMC

Simpson A.J., Honkoop P.J., Kennington E., et al. Perspectives of patients and healthcare professionals on mHealth for asthma self-management. Eur Respir J. 2017;49(5) PubMed

Bousquet J., Ansotegui I.J., Anto J.M., et al. Mobile technology in allergic rhinitis: evolution in management or revolution in health and care? J Allergy Clin Immunol Pract. 2019;7(8):2511–2523. PubMed

Pattini S., Malizia V., Travaglini A., et al. Telemedicine for allergic patients during COVID-19. Pediatr Allergy Immunol. 2020;31(Suppl 26):102–104. PubMed PMC

Tinschert P., Jakob R., Barata F., Kramer J.N., Kowatsch T. The potential of mobile apps for improving asthma self-management: a review of publicly available and well-adopted asthma apps. JMIR Mhealth Uhealth. 2017;5(8):e113. PubMed PMC

Aung Y.Y.M., Wong D.C.S., Ting D.S.W. The promise of artificial intelligence: a review of the opportunities and challenges of artificial intelligence in healthcare. Br Med Bull. 2021;139(1):4–15. PubMed

Camacho-Rivera M., Vo H., Huang X., Lau J., Lawal A., Kawaguchi A. Evaluating asthma mobile apps to improve asthma self-management: user ratings and sentiment analysis of publicly available apps. JMIR Mhealth Uhealth. 2020;8(10):e15076. PubMed PMC

Lombardi C., Bonini M., Passalacqua G. The role of mobile apps in allergic respiratory diseases: an Italian multicentre survey report. Eur Ann Allergy Clin Immunol. 2018;50(6):268–272. PubMed

Van Bulck P., Cools L., Soumya M.S., et al. A multicenter real-life study on the multiple reasons for uncontrolled allergic rhinitis. Allergy Rhinol. 2021;11(10):1452–1460. PubMed

Stoyanov S.R., Hides L., Kavanagh D.J., Zelenko O., Tjondronegoro D., Mani M. Mobile app rating scale: a new tool for assessing the quality of health mobile apps. JMIR Mhealth Uhealth. 2015;3(1):e27. PubMed PMC

Stoyanov S.R., Hides L., Kavanagh D.J., Wilson H. Development and validation of the user version of the mobile application rating scale (uMARS) JMIR Mhealth Uhealth. 2016;4(2):e72. PubMed PMC

Bravo P., Edwards A., Barr P.J., Scholl I., Elwyn G., McAllister M. Conceptualising patient empowerment: a mixed methods study. BMC Health Serv Res. 2015;15:252. PubMed PMC

Hellings P.W., Borrelli D., Pietikainen S., et al. European summit on the prevention and self-management of chronic respiratory diseases: report of the European union parliament summit (29 March 2017) Clin Transl Allergy. 2017;7:49. PubMed PMC

Bousquet J., Addis A., Adcock I., et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs) Eur Respir J. 2014;44(2):304–323. PubMed

Sofiev M., Palamarchuk Y., Bédard A., et al. A demonstration project of global alliance against chronic respiratory diseases: prediction of interactions between air pollution and allergen exposure-the mobile airways sentinel NetworK-impact of air POLLution on asthma and rhinitis approach. Chin Med J (Engl). 2020;133(13):1561–1567. PubMed PMC

Pizzulli A., Perna S., Florack J., et al. The impact of telemonitoring on adherence to nasal corticosteroid treatment in children with seasonal allergic rhinoconjunctivitis. Clin Exp Allergy. 2014;44(10):1246–1254. PubMed

Tran N., Coffman J.M., Sumino K., Cabana M.D. Patient reminder systems and asthma medication adherence: a systematic review. J Asthma. 2014;51(5):536–543. PubMed

Breiteneder H., Peng Y.Q., Agache I., et al. Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma. Allergy. 2020;75(12):3039–3068. PubMed PMC

Honkoop P.J., Simpson A., Bonini M., et al. MyAirCoach: the use of home-monitoring and mHealth systems to predict deterioration in asthma control and the occurrence of asthma exacerbations; study protocol of an observational study. BMJ Open. 2017;7(1):e013935. PubMed PMC

Bousquet J., Caimmi D.P., Bedbrook A., et al. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy. 2017;72(6):857–865. PubMed

https://ec.europa.eu/digital-single-market/en/news/code-conduct-privacy-mhealth-apps-has-been-finalised CoCopfmahbfIAf.

Rowland S.P., Fitzgerald J.E., Holme T., Powell J., McGregor A. What is the clinical value of mHealth for patients? NPJ Digit Med. 2020;3:4. PubMed PMC

Huckvale K., Morrison C., Ouyang J., Ghaghda A., Car J. The evolution of mobile apps for asthma: an updated systematic assessment of content and tools. BMC Med. 2015;13:58. PubMed PMC

Schwamm L.H. Telehealth: seven strategies to successfully implement disruptive technology and transform health care. Health Aff (Millwood). 2014;33(2):200–206. PubMed

Prokopakis E., Vardouniotis A., Bachert C., et al. Rhinology future debates 2018, a EUFOREA report. Rhinology. 2020;58(4):384–393. PubMed

Hellings P.W., Fokkens W.J., Bachert C., et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - a EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297–1305. PubMed

Commission E. GREEN PAPER on mobile Health (mHealth). [Internet] Available from: https://eceuropaeu/digital-single-market/en/news/green-paper-mobile-health-mhealth [Internet]..

Stephani V., Opoku D., Quentin W. A systematic review of randomized controlled trials of mHealth interventions against non-communicable diseases in developing countries. BMC Publ Health. 2016;16:572. PubMed PMC

Beratarrechea A., Lee A.G., Willner J.M., Jahangir E., Ciapponi A., Rubinstein A. The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review. Telemed J e Health. 2014;20(1):75–82. PubMed PMC